Sign inGet started

Larkin Cristina

Insider CIK 1721173 · SPRO Chief Operating Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SPRO Spero Therapeutics, Inc. A Award deriv2022-02-012022-02-0353,190— $053,190SEC↗
SPRO Spero Therapeutics, Inc. A Award2022-02-012022-02-0338,014— $063,581SEC↗
SPRO Spero Therapeutics, Inc. A Award2021-08-262021-08-3024,067— $025,567SEC↗
SPRO Spero Therapeutics, Inc. A Award deriv2021-02-012021-02-0357,432— $057,432SEC↗
SPRO Spero Therapeutics, Inc. M Exercise deriv2020-12-162020-12-1812,000— $08,434SEC↗
SPRO Spero Therapeutics, Inc. S Sale2020-12-162020-12-1812,000$19.00 $228.0K1,500SEC↗
SPRO Spero Therapeutics, Inc. M Exercise2020-12-162020-12-1812,000$5.90 $70.8K13,500SEC↗
SPRO Spero Therapeutics, Inc. A Award deriv2020-02-032020-02-0355,000— $055,000SEC↗
SPRO Spero Therapeutics, Inc. A Award deriv2019-01-022019-01-0265,000— $065,000SEC↗
SPRO Spero Therapeutics, Inc. M Exercise deriv2018-07-052018-07-064,000— $020,434SEC↗
SPRO Spero Therapeutics, Inc. S Sale2018-07-052018-07-064,000$17.50 $70.0K1,500SEC↗
SPRO Spero Therapeutics, Inc. M Exercise2018-07-052018-07-064,000$5.90 $23.6K5,500SEC↗
SPRO Spero Therapeutics, Inc. A Award deriv2017-12-132017-12-1562,540— $062,540SEC↗
SPRO Spero Therapeutics, Inc. P Buy2017-11-062017-11-071,500$14.00 $21.0K1,500SEC↗